Literature DB >> 10918575

Genetic dissection of c-myc apoptotic pathways.

C E Nesbit1, J M Tersak, L E Grove, A Drzal, H Choi, E V Prochownik.   

Abstract

All biological functions mediated by the c-myc oncoprotein require an intact transactivation domain (TAD). We compared TAD mutants for their ability to promote apoptosis of 32D myeloid cells in response to interleukin-3 (IL-3) deprivation and exposure to chemotherapeutic drugs, and to activate ornithine decarboxylase, an endogenous c-myc target. Different sub-regions of the TAD were required to mediate each function. cDNA microarrays were then used to identify multiple c-myc-regulated transcripts, some of which were also modulated by IL-3 or cytotoxic drugs, as well as by specific sub-regions of the TAD. Several of the c-myc-regulated transcripts had also been previously identified as targets for IFN-gamma. The functional consequences of their deregulation were manifested by a marked sensitivity of c-myc-overexpressing cells to IFN-gamma-mediated apoptosis. Our results establish that several well-characterized functions of c-myc are separable and correlate with the expression of a novel group of target genes, some of which also mediate the apoptotic action of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10918575     DOI: 10.1038/sj.onc.1203636

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  16 in total

Review 1.  Cell cycle and apoptosis.

Authors:  Katrien Vermeulen; Zwi N Berneman; Dirk R Van Bockstaele
Journal:  Cell Prolif       Date:  2003-06       Impact factor: 6.831

2.  Deregulation of common genes by c-Myc and its direct target, MT-MC1.

Authors:  Kenneth R Rogulski; Debra E Cohen; David L Corcoran; Panayiotis V Benos; Edward V Prochownik
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-19       Impact factor: 11.205

3.  Apoptotic role of IKK in T-ALL therapeutic response.

Authors:  Irene Riz; Lynnsey A Zweier-Renn; Ian Toma; Teresa S Hawley; Robert G Hawley
Journal:  Mol Cancer Res       Date:  2011-07-05       Impact factor: 5.852

4.  Emerging Concepts in the Analysis of Transcriptional Targets of the MYC Oncoprotein: Are the Targets Targetable?

Authors:  Chi Van Dang; Steven B McMahon
Journal:  Genes Cancer       Date:  2010-06

5.  The negative c-Myc target onzin affects proliferation and apoptosis via its obligate interaction with phospholipid scramblase 1.

Authors:  Youjun Li; Kenneth Rogulski; Quansheng Zhou; Peter J Sims; Edward V Prochownik
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

6.  MYC prevents apoptosis and enhances endoreduplication induced by paclitaxel.

Authors:  Giuliana Gatti; Giovanna Maresca; Manuela Natoli; Fulvio Florenzano; Angelo Nicolin; Armando Felsani; Igea D'Agnano
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

7.  Point mutations in c-Myc uncouple neoplastic transformation from multiple other phenotypes in rat fibroblasts.

Authors:  J Anthony Graves; Kristi Rothermund; Tao Wang; Wei Qian; Bennett Van Houten; Edward V Prochownik
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  A functional screen for Myc-responsive genes reveals serine hydroxymethyltransferase, a major source of the one-carbon unit for cell metabolism.

Authors:  Mikhail A Nikiforov; Sanjay Chandriani; Brenda O'Connell; Oleksi Petrenko; Iulia Kotenko; Andrew Beavis; John M Sedivy; Michael D Cole
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

9.  Gene expression analysis in Interleukin-12-induced suppression of mouse mammary carcinoma.

Authors:  Xiaoyan Shi; Jianguo Liu; Zhaoying Xiang; Maki Mitsuhashi; Rita S Wu; Xiaojing Ma
Journal:  Int J Cancer       Date:  2004-07-01       Impact factor: 7.396

10.  Loss of protooncogene c-Myc function impedes G1 phase progression both before and after the restriction point.

Authors:  Christoph Schorl; John M Sedivy
Journal:  Mol Biol Cell       Date:  2003-03       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.